PMDA’s Review Division Remains in the Red, with Loss of 2-2.5 Billion Yen Expected for Full Year

The review division of the Pharmaceuticals and Medical Devices Agency (PMDA) cannot break out of its deficit. The division posted in this fiscal year an ordinary loss of 749 million yen as of the end of August, up 396 million...read more